Charles River Laboratories Provides Business Updates
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Business Wire
– Signs Agreement to Acquire K.F. (Cambodia) Ltd. to Further Strengthen DSA Supply Chain; Transaction Expected to be Accretive to Non-GAAP Earnings Per Share by Approximately $0.25 in 2026 and Approximately $0.60 in 2027 –– Exercises Option to Acquire PathoQuest SAS to Enhance NAMs Capabilities for Rapid, In Vitro Manufacturing Quality-Control Testing –– Names Former FDA Deputy Principal Commissioner Dr. Namandjé Bumpus as Senior Vice President, Chief Scientific and Innovation Officer –– Providing Update on Recent Business Trends and Preliminary 2026 Outlook at J.P. Morgan Healthcare Conference – WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced two planned acquisitions of K.F. (Cambodia) Ltd. and PathoQuest SAS; the addition of Dr. Namandjé N. Bumpus as Chief Scientific and Innovation Officer; and is also providing an update on recent business trends and a preliminary 2026 outlook at the J.P. Morgan 44th Annual Healthcar
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- A Look At Charles River Laboratories (CRL) Valuation After Planned CEO Transition And Governance Shift [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International (NYSE:CRL) was given a new $224.00 price target on by analysts at Robert W. Baird.MarketBeat
- Charles River Laboratories International (NYSE:CRL) was given a new $215.00 price target on by analysts at Mizuho.MarketBeat
- Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession PlanBusiness Wire
CRL
Earnings
- 11/5/25 - Beat
CRL
Sec Filings
- 1/9/26 - Form 8-K
- 12/3/25 - Form 8-K
- 11/17/25 - Form 8-K
- CRL's page on the SEC website